Review: taking Imodium and Dicyclomine hydrochloride together


Summary

Drug interactions are reported among people who take Imodium and Dicyclomine hydrochloride together. This review analyzes the effectiveness and drug interactions between Imodium and Dicyclomine hydrochloride. It is created by eHealthMe based on reports of 261 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Imodium and Dicyclomine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Imodium

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. (latest outcomes from Imodium 9,946 users)

Dicyclomine Hydrochloride

Dicyclomine hydrochloride has active ingredients of dicyclomine hydrochloride. It is often used in irritable bowel syndrome. (latest outcomes from Dicyclomine hydrochloride 642 users)

On Jul, 27, 2016

261 people who take Imodium, Dicyclomine Hydrochloride are studied.


Number of reports submitted per year:

Imodium and Dicyclomine hydrochloride drug interactions.

Drug effectiveness over time:

Imodium:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Dicyclomine Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Imodium:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 1 people)
Dicyclomine Hydrochloride:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Imodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Dicyclomine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • acute graft versus host disease
  • c-reactive protein increased
  • diarrhoea
  • epstein-barr virus infection
  • hepatic function abnormal
  • hyperamylasaemia
  • hypomagnesaemia
  • infection
  • lymphoproliferative disorder
  • mucous membrane disorder
1 - 6 months:
  • diarrhoea
  • epstein-barr virus infection
  • diarrhea
  • insomnia
  • knee pain
  • nausea
  • pain - back
  • pain in jaw
  • acute graft versus host disease
  • c-reactive protein increased
2 - 5 years:
  • anxiety
  • depression
not specified:
  • nausea
  • abdominal pain
  • diarrhoea
  • vomiting
  • pain
  • pyrexia
  • weight increased
  • crohn's disease
  • depression
  • abdominal pain lower

Most common drug interactions by gender *:

female:
  • abdominal pain
  • nausea
  • diarrhoea
  • weight increased
  • depression
  • pain
  • abdominal pain upper
  • pyrexia
  • vomiting
  • back pain
male:
  • vomiting
  • diarrhoea
  • nausea
  • crohn's disease
  • blood potassium decreased
  • pain
  • abdominal pain lower
  • colitis
  • dysgeusia
  • eructation

Most common drug interactions by age *:

10-19:
  • colitis ulcerative
  • diarrhoea
  • gastrointestinal haemorrhage
  • abdominal pain upper
  • abscess
  • chest pain
  • dyspepsia
  • eructation
  • faecal incontinence
  • haemorrhoids
20-29:
  • abdominal pain
  • biliary colic
  • cholecystitis acute
  • epigastric discomfort
  • post cholecystectomy syndrome
  • upper respiratory tract infection
  • cholecystitis chronic
  • gallbladder injury
  • chest discomfort
  • chest pain
30-39:
  • crohn's disease
  • vomiting
  • abdominal pain lower
  • blood potassium decreased
  • colitis
  • dysgeusia
  • eructation
  • pernicious anaemia
  • quadriplegia
  • drug dependence
40-49:
  • abdominal pain
  • dyspnoea exertional
  • swelling
  • weight increased
  • oedema
  • depression
  • drug ineffective
  • fluid overload
  • type 2 diabetes mellitus
  • pain
50-59:
  • pyrexia
  • weight decreased
  • diarrhoea
  • nausea
  • pain
  • back pain
  • pneumonia
  • weight increased
  • arthralgia
  • hypoaesthesia
60+:
  • nausea
  • diarrhoea
  • vomiting
  • depression
  • abdominal pain
  • pain
  • fall
  • tremor
  • asthenia
  • international normalised ratio increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Imodium and Dicyclomine hydrochloride?

Can you answer these questions?

More questions for: Imodium, Dicyclomine hydrochloride

You may be interested in these reviews

More reviews for: Imodium, Dicyclomine hydrochloride

On eHealthMe, Imodium (loperamide hydrochloride) is often used to treat diarrhea. Dicyclomine hydrochloride (dicyclomine hydrochloride) is often used to treat irritable bowel syndrome. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.